Thomas John Dietz, Director at Paratek Pharmaceuticals, Inc. (PRTK), sold 3,000 shares at $7.14 ($21K) on 2019-02-15, disclosed to the SEC on 2019-02-20.
Scheduled sale ($21k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EIGR | SELL | 2022-12-27 | $26K | — | Filing → |
| EIGR | BUY | 2021-04-12 | $21K | — | Filing → |
| EIGR | BUY | 2020-03-17 | $5K | — | Filing → |